Lee YW - Search Results

1

Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study.

Han HS, Kim WS, Lee YW, Won CH, Lee W, Choi SY, Kim BJ. Han HS, et al. Among authors: lee yw. J Dermatolog Treat. 2024 Dec;35(1):2418919. doi: 10.1080/09546634.2024.2418919. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462517 Free article.

2

A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of PP-501-B in correction of nasolabial folds.

Park KY, Ko EJ, Kim BJ, Kim MN, Hong CK, Chang SE, Won CH, Lee YW. Park KY, et al. Among authors: lee yw. Dermatol Surg. 2015 Jan;41(1):113-20. doi: 10.1097/DSS.0000000000000203. Dermatol Surg. 2015. PMID: 25521103 Clinical Trial.

3

Effects of highly concentrated hyaluronic acid filler on nasolabial fold correction: A 24-month extension study.

Noh TK, Moon HR, Yu JS, Chang SE, Moon IJ, Choi SY, Oh WJ, Won CH, Kim BJ, Lee YW. Noh TK, et al. Among authors: lee yw. J Dermatolog Treat. 2016 Nov;27(6):510-514. doi: 10.3109/09546634.2016.1170759. Epub 2016 Apr 28. J Dermatolog Treat. 2016. PMID: 27121901 Free article. Clinical Trial.

4

Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.

Cheon HI, Jung N, Won CH, Kim BJ, Lee YW. Cheon HI, et al. Among authors: lee yw. Dermatol Surg. 2019 Dec;45(12):1610-1619. doi: 10.1097/DSS.0000000000001920. Dermatol Surg. 2019. PMID: 30893169 Clinical Trial.

5

Efficacy and Safety of a New Botulinum Toxin (HU-014) Versus Existing Onabotulinumtoxin A in Subjects With Moderate to Severe Glabellar Lines.

Yoo KH, Lee YW, Lee JS, Kwon SH, Huh CH, Kim BJ. Yoo KH, et al. Among authors: lee js, lee yw. Dermatol Surg. 2021 Mar 1;47(3):e91-e96. doi: 10.1097/DSS.0000000000002789. Dermatol Surg. 2021. PMID: 33481449 Clinical Trial.

6

Phase I/III Clinical Trial to Evaluate the Safety and Efficacy of a New Botulinum Toxin (HU-014) Versus OnabotulinumtoxinA in Subjects With Moderate-to-Severe Crow's Feet Lines.

Han HS, Yoo KH, Lee JS, Huh CH, Kwon SH, Lee YW, Kim BJ. Han HS, et al. Among authors: lee js, lee yw. Dermatol Surg. 2021 Apr 1;47(4):e127-e131. doi: 10.1097/DSS.0000000000002807. Dermatol Surg. 2021. PMID: 33795571 Clinical Trial.

7

A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.

Lee JS, Son HS, Kim BJ, Lee YW. Lee JS, et al. Among authors: lee yw. Plast Reconstr Surg. 2024 May 1;153(5):910e-918e. doi: 10.1097/PRS.0000000000010840. Epub 2023 Jun 19. Plast Reconstr Surg. 2024. PMID: 37335589 Clinical Trial.

8

Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study.

Seok J, Koh YG, Hong JK, Yun SH, Kim DH, Son HS, Choi SY, Yoo KH, Lee YW, Kim BJ. Seok J, et al. Among authors: lee yw. Dermatol Surg. 2024 Jun 1;50(6):527-533. doi: 10.1097/DSS.0000000000004146. Epub 2024 Mar 8. Dermatol Surg. 2024. PMID: 38518110 Clinical Trial.

9

A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.

Choi SY, Koh YG, Lee YW, Son HS, Yoon YN, Kim G, Won C, Cho H, Son JS, Kim EK, Kim BJ. Choi SY, et al. Among authors: lee yw. J Dermatolog Treat. 2024 Dec;35(1):2359511. doi: 10.1080/09546634.2024.2359511. Epub 2024 Jun 16. J Dermatolog Treat. 2024. PMID: 38880494 Free article. Clinical Trial.

10

The efficacy and safety of a monophasic hyaluronic acid filler in the correction of nasolabial folds: A randomized, multicenter, single blinded, split-face study.

Kwon HJ, Ko EJ, Choi SY, Choi EJ, Jang YJ, Kim BJ, Lee YW. Kwon HJ, et al. Among authors: lee yw. J Cosmet Dermatol. 2018 Aug;17(4):584-589. doi: 10.1111/jocd.12380. Epub 2017 Sep 14. J Cosmet Dermatol. 2018. PMID: 28913927 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,557 results

Search Page

Filters